DAPAGLIFLOZIN AND SAXAGLIPTIN (QTERN) Nursing Considerations

What is the generic name?

DAPAGLIFLOZIN AND SAXAGLIPTIN

What is the Trade Name for DAPAGLIFLOZIN AND SAXAGLIPTIN?

QTERN

What are the Indications for DAPAGLIFLOZIN AND SAXAGLIPTIN?

• 1 INDICATIONS AND USAGE QTERN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use QTERN is not recommended for patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients [see WARNINGS AND PRECAUTIONS (5.3) ] . QTERN is a combination of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor and saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1) Limitations of Use : QTERN is not for treatment of type 1 diabetes mellitus. (1)

References: https://open.fda.gov/